United Therapeutics CEO Martine A. Rothblatt reports $5.59 million common-share sale
UTHR•United Therapeutics Chairperson and CEO Martine A. Rothblatt sold 9,500 common shares on Oct. 26, 2026, at weighted-average prices ranging from $585.7122 to $592.9168 per share. She also exercised options for 9,500 shares at $117.76 each.
1. Share transactions
Rothblatt sold 9,500 common shares on Oct. 26, 2026, at weighted-average prices ranging from $585.7122 to $592.9168 per share, and exercised options for 9,500 common shares at $117.76 per share. After the transactions, 324,443 common shares were held indirectly through trusts involved in the trades, while direct holdings totaled 40,513 shares.
